2017 WBL Board Program Speakers

Tina-Marie Adams, Managing Director, APCO Worldwide
Speaker - Are you famous? Increasing your reputation and visibility in your industry
Adams, Tina-Marie.jpg

Tina-Marie Adams is managing director of APCO Worldwide’s Chicago office. With nearly 20 years of experience in the region, Ms. Adams specializes in corporate communication and public affairs, including issues/crisis management, reputation management and labor relations. She leads key initiatives and provides strategic counsel to clients in a variety of sectors including health care, energy, transportation, higher education, food and consumer retail.

Prior to joining APCO, Ms. Adams served as senior client director and Midwest regional director at Ketchum, where she led key organizational change initiatives and worked with professionals including C-level executives on critical business issues. Before her time at Ketchum, she held senior management roles at MWW Group and Hill & Knowlton, where she developed proprietary, trademarked efforts and was recognized for leading new business and growth efforts in the Midwest region.

Ms. Adams is a former journalist with the Chicago Tribune and Gannett newspapers. She holds a bachelor’s degree from Butler University, where she graduated summa cum laude, and a master’s degree from Northwestern University’s Medill School of Journalism.

Katie Bell, Senior Client Partner, Korn Ferry
Speaker - Insights from a global search firm: who boards are seeking and understanding the interview process

Katie Bell is a Senior Client Partner at Korn/Ferry and a Global Account Lead in the Healthcare Sector.  Prior to this, she was at another global executive search firm, where she was Partner, Healthcare and Life Sciences. During this time, she was a member of the Healthcare Leadership team, served as culture champion for the Southeast region, and was Human Resource Functional Practice Lead for Healthcare.

Prior to this role, Katie served in several leadership positions at the Advisory Board Company and Gallup, where she worked closely with senior leadership to design research content, innovative industry products and key global events to drive business growth. She also holds extensive consulting experience with focus on organizational development, talent management and workforce wellness.

Katie holds a Bachelor of Science degree in Business Education from the University of Nebraska-Lincoln and has completed Executive Education coursework at Harvard University in Cambridge. She is an advisory board member for WBL and HINRI (The Healthcare Institute for National Renewal and Innovation). She is a published author and frequent guest speaker.

Jan Berger, MD, MJ, President & CEO, Health Intelligence Partners; Vice Chair, GNS Healthcare; Chair of the Board, AccentCare; Board Member, Savor Health, Whiskerdocs, University of Arizona School of Pharmacy, Harvard Patient Safety Board, Midwest Business Group on Health
Panelist - The interview & diligence process: what to consider
Berger, Jan.png

Jan founded Health Intelligence Partners six years ago as a health care consultancy that blends more than thirty years of business and clinical experience. Health Intelligence Partners has a global focus, working with clients on both short -term and long-term healthcare business strategies and solutions. Jan and Health Intelligence Partners help clients navigate the healthcare environment in order to identify and articulate value opportunities. A great deal of Jan’s focus is on consumer engagement and how it affects the decisions that the consumer makes and the actions that they take.

Prior to founding Health Intelligence Partners, Jan served as Senior Vice President and Chief Clinical Officer for CVS Caremark. During that time, she had Executive Management, P & L, Operations, Innovation and Strategy responsibilities. Before going to CVS Caremark, Jan had 15 years’ experience in healthcare administration within the health plan and academic arenas and lead operations for two population health companies.

As a veteran healthcare executive, Jan’s leadership has delivered results in a variety of settings. Jan offers her experiences and insights through her consulting agency as well as through her participation on healthcare and consumer product boards. She presently sits on healthcare focused boards including AccentCare (Chair; Compliance Committee, Compensation Committee), GNS Healthcare, The University of Arizona School of Pharmacy, Harvard Patient Safety Board, Midwest Business Group on Health and Population Health Alliance (Chair: Government Affairs Committee). Jan’s consumer focused boards include Meals to Heal and Whiskerdocs. Jan previously sat on two boards; Care Core National (Committees: Chari: Finance Past Chairperson, Compensation, Search, M&A and Strategic Directions) and Rx-Ante, which were recently sold. She also sits on numerous business and healthcare committees.

As the author of the books “Leveraging Health” and “Thirteen Common Pitfalls in Consumer Engagement” and “Medical Liability for Pediatricians”, the Editor in Chief of American Journal of Pharmacy Benefit and on the editorial boards of a number of healthcare journals, Jan is considered a national health care thought leader. Jan speaks and writes on a broad range of health care issues.

Jan holds both a Doctor of Medicine degree and a Master’s degree in Jurisprudence from Loyola University in Chicago and a Certificate in Healthcare Business Administration from University of South Florida. She also holds a black belt in Six Sigma. Jan is an assistant professor at Northwestern University School of Medicine in Chicago, Illinois.

Paul Brooke, Board Member, Incyte Corporation (NASDAQ: INCY), Cheyne Capital International and Manning & Napier (NYSE: MN)
Panelist - How do nominating committees and boards evaluate candidates?
Brooke, Paul.jpg

Paul Brooke has over 30 years of experience in life science analysis, investing, and management. Mr. Brooke was the Global Head of Health Care Research and Strategy for Morgan Stanley and headed up Morgan Stanley Research, Strategy, and Economics in the Pacific Basin including Japan. He was also responsible for health care investing for Tiger Management. He is a Director of Incyte Corporation, Cheyne Capital International and Manning & Napier. He has also served on numerous boards including WebMD, Transform, ViroPharma and Novirio. Mr. Brooke has played an active role in managing the growth of many companies in the biotech sector. Through his role as Chairman and CEO of Ithaka, he structured the purchase of Alsius Corp and successfully sold its assets to Zol Medical in 2008. He was an advisor to MPM Capital and a Member of the Board of Directors of the MPM BioEquities Fund. Mr. Brooke is a Managing Member of PMSV Holdings (an investment firm), and a former Managing Director of Tiger Management.

Cindy Chandler, Chief Corporate Officer & Managing Director, Wheless Partners Executive Search, Inc.
Moderator - Exceeding expectations as an effective new director
Chandler, Cindy.jpg

As founder and CEO of retained executive search firm Chandler Group, Cindy has served premier clients in a wide array of industry sectors including healthcare, non-profit, manufacturing, financial services, and consumer products, delivering top tier leadership in the functional areas of finance, human resources, senior management, sales and marketing, communications, operations, and more. Cindy began her career of executive recruiting in 1995 in a New York based international search firm. Prior to her career in executive search, Cindy spent fifteen years with American Express Financial Advisors and Piper Jaffray.

Cindy’s total commitment to client service, her reputation for meticulous attention to detail, and her depth of industry knowledge are endorsed by her many repeat clients who view Cindy as a true trusted advisor in leadership initiatives from the board level and in key executive and management roles. Cindy has helped build effective and diverse boards for a broad array of enterprises, including a robotics company where she has placed generals and other top military leaders; multiple non-profit organizations including Volunteers of America and Delta Dental; publicly traded companies including Tennant Company; and private equity holdings such as Vision Ease. Her expertise in facilitating skills assessment and developing and implementing talent pipeline strategies have benefited many enterprises including United Way of Twin Cities and others.

Cindy currently serves on the Advisory Board for WBL and is a former board member of Women’s Health Leadership TRUST.  Business Leaders in Healthcare in America. An active community volunteer for many years, Cindy’s community service includes board leadership for Project for Pride in Living, Juvenile Diabetes and Children’s Cancer Research Fund. Cindy received her BA from the University of Minnesota.

Barbara Colwell, Board Member, Northern Technologies International Corporation (NASDAQ: NTIC), Publisher's Clearing House and Mutual Trust Life Insurance
Speaker - Advisory boards: a unique way to serve and grow
Colwell, Barbara.jpg

Barbara Colwell is a corporate and not for profit director.  She previously held senior management positions with priceline.com, CIGNA and TWA.   

In addition to Publishers Clearing House, she also serves on the board of Northern Technologies International Corporation.  Previously she served on the boards of Mutual Trust Financial Group, Indemnity Insurance Company of NA, Innovation Network (Chair 2005-7) and ThinkQuest NYC. 

Barbara also serves on several advisory boards including Mutual Trust Life Insurance Company, IPTAR (Institute for Psychoanalytic Training and Research), and POBA:  Where the Arts Live.  In the past she also served on advisory boards for WomenCorporateDirectors, AMEC Americas, GG Bailey, the communications committee of the Council on Competitiveness and the marketing council of the American Management Association.  She also served on advisory boards for Avis, KindMark and tourist boards of Great Britain, Israel and Denmark.

Current professional affiliations include WomenCorporateDirectors, the International Women’s Forum where she co-chaired the program committee until Jan. 2017, and The Belizean Grove where she chairs the finance committee and serves on the Membership and Executive committees. Previously she was a member of NACD (National Association of Corporate Directors) and she co-chaired the NY chapter of the National Women’s History Museum from 2009 until 2011. 

As an adjunct professor at the Elliott School of International Affairs at GW University, she co-taught a graduate course for several years on “Global Visions, Strategies and Tactics for International Organizations”. 

Ms. Colwell earned her MBA from Columbia University.  She resides in New York City.   

Nancy Donohoo, Washington University in St. Louis and Advisory Board Member, WBL Foundation
Speaker - Crafting and Implementing your Personal Strategic Plan of Action for Board Service
Donohoo, Nancy.jpg

Nancy’s health care industry experience spans over 20 years. Presently, she serves as Senior Consultant, University Executive Recruitment at Washington University in St. Louis. Previously, she spent 17 years as a Partner/Vice President at several national healthcare executive search firms where she conducted engagements on behalf of integrated delivery systems, life sciences companies, payers, and health services organizations.  Nancy has partnered with a broad range of clients including nonprofit, early stage/high-growth, as well as large publicly traded companies with a focus on senior executive talent and physician executives.  Over the course of her career, Nancy has served many prominent clients including: GE HealthCare, Pfizer, Mallinckrodt, CIGNA, Aetna, UPMC Health Plan, Nationwide Children’s, and Children’s HealthCare of Atlanta.  

Outside the search industry, Nancy held leadership roles at United HealthCare, Coventry, and KV Pharmaceutical.  Early in her career, Nancy founded, built, and later sold a corporate wellness and fitness outsourcing company, Corporate Health Systems, providing staffing and programming to Fortune 500 companies nationwide.

Nancy serves as an advisory board member to WBL (Women Business Leaders of the U.S. Health Care Industry Foundation). She has also held volunteer leadership roles for the HBA (Healthcare Business Women’s Association), including President of the St. Louis Chapter. Nancy holds a B.S. degree in business/industrial communications and a M.Ed. degree in education.  She is a certified executive coach and a behavioral interviewing instructor. She enjoys presenting on talent/leadership related topics.

Sarah Eames, Senior Member, Russell Reynolds Associates
Moderator - How do nominating committees and boards evaluate candidates?

Sarah Ladd Eames, based in New York, is a senior member of the Russell Reynold’s CEO/Board Services, Health Services, and global Life Sciences Practices. She specializes in succession planning and recruiting CEOs, senior executive leaders and board members for healthcare services, health plans, pharmaceutical, and diagnostics companies. She serves a diverse group of clients comprised of Fortune 500, mid-cap and emerging growth companies in the United States and Europe. In the Health Services sector, she has recruited for multisite for-profit and private equity healthcare services companies, managed care organizations and integrated delivery systems. She is the Co-Founder of Russell Reynolds Associates' CEO Roundtable for Healthcare CEOs.

A seasoned health care industry executive, Sarah possesses more than 25 years of diverse healthcare services and board of director experience in both the public and private sectors including Trinity Health. Prior to joining Russell Reynolds Associates, Sarah was the Deputy Chairman and CEO of the publicly-traded Allied Healthcare International, Inc. She also held roles of increasing responsibility at American Hospital Supply Corporation, Apria Healthcare Group, Baxter International, and Johnson & Johnson.

Sarah is a board member and serves on the board of directors of the Visiting Nursing Services of New York and the advisory board of the Smithsonian Libraries. She is a member of the Economic Club of New York.

Sarah received her B.A. in economics from Northwestern University, Phi Beta Kappa, and her M.B.A. from the University of California, Irvine.

Mary Flipse, Chief Legal & Administrative Officer, Tivity Health (NASDAQ: TVTY)
Moderator - Locating and securing public board opportunities
Flipse, Mary.jpg

As Chief Legal & Administrative Officer, Mary S. Flipse has responsibility for the legal and contracting functions, as well as human resources, government relations and corporate communications. Flipse joined Tivity Health, Inc in 2011 and assumed the role of General Counsel and Assistant Secretary in 2012. She became Chief Legal Officer in 2015.

Mary's legal career spans more than twenty years. Before joining Tivity Health, Inc, Mary served as a Vice President and Assistant General Counsel with King Pharmaceuticals, Inc. Prior to that, she was with the American law firm, White & Case, in Bangkok Thailand. Mary began her legal career as the founding partner of Dirksen Flipse Doran & Le, the first international law offices in Laos and Cambodia.

Mary earned a Juris Doctor degree from Georgetown University Law Center in Washington, DC, and a Bachelor of Arts from Middle Tennessee State University in Murfreesboro, Tennessee.

Alyse Forcellina, Healthcare & Americas Practice Leader, Egon Zehnder
Moderator - The interview & diligence process: what to consider

Alyse Forcellina, based in New York, advises clients on broad-ranging talent matters, including organizational design, leadership assessment and development, and succession planning. Alyse leads the Americas Healthcare practice, working with biopharma and healthcare services companies to find top executive talent and Board members. Leveraging her background in strategy and finance, Alyse helps organizations harness talent to meet their strategic and operational goals within the ever-changing global marketplace. She is certified in the 16pf and the Hogan Development survey, and is trained in a variety of leadership and coaching frameworks.

Prior to joining Egon Zehnder, Alyse was an Associate Principal at McKinsey & Company, where she helped healthcare clients solve both commercial and organizational challenges, with a particular emphasis on capability building. As a Senior Principal at IMS Consulting, she was a leader in the North American practice, where she helped double revenues and developed a best-in-class leadership team. Previously, she was Managing Director of True North Partners, a boutique healthcare consultancy, where she built the consulting practice. Earlier in her career, Alyse was an Associate with a boutique investment bank, advising biotech, diagnostics and medical device companies on M&A transactions and capital structure. She started her career on Capitol Hill working for a United States Senator, writing healthcare legislation.

Alyse earned a BA in American Studies at Yale, an MPAff from Lyndon B. Johnson School of Public Affairs and an MBA from McCombs School of Business, both at the University of Texas. 

Karen Griffith Gryga, Managing Partner and Chief Investment Officer, Dreamit Ventures, and Founder, Dreamit Health and Dreamit Athena
Speaker - Start at the beginning: how startups and early stage companies can help advance your governance goals

Karen is currently Chief Investment Officer of DreamIt Ventures in charge of DreamIt Funds. DreamIt Ventures is a top startup accelerator which brings in promising early-stage companies for a 4 month program where we focus on validating and de-risking the business opportunity through intensive hands-on work. The companies have the opportunity to leverage a large amount of resources including personally sourced mentors, speakers, subject matter experts, advisors, investors and other domain specific and startup resources. The goal of Dreamit is to help entrepreneurs achieve in 3-6 months what typically takes them 12-24 months to achieve on their own. DreamIt has launched over 300 companies since 2008. Karen is also founder of the DreamIt Athena program focused on Female Founders.

Karen was formerly Co-Founder & CEO of FashInvest. The goal of FashInvest is to create a community of key participants to foster the development of the emerging growth companies within the sectors of Branded Goods, Retail, Fashion and Technologies related to these consumer opportunities. FashInvest is focused on creating one of the most respected business platforms committed to company growth and formation. We are building the community both through live events and through the website. The FashInvest Capital Conference is the only capital conference focused on these sectors in the world.

Prior to her current roles, Karen had many years of venture capital and private equity experience with four firms; Context Capital Partners, Liberty Venture Partners, Philadelphia Ventures and the Mid-Atlantic Angel Group. Karen's focus through her venture career was on early stage technology investing. Notable investments included Synchronoss Technologies (NASDAQ: SNCR), Liveprint (acquired by Kinkos), InSoft (acquired by Netscape), Cadis (acquired by Aspect Development), and Sofnet (acquired by Global Village Communication).

Adele Gulfo, EVP & Head of Global Commercial Development, Mylan and Director, Bemis, Inc.
Panelist - Locating and securing public board opportunities
Gulfo, Adele.jpg

Adele Gulfo serves as Mylan’s Head of Global Commercial Development and is on the Board of Directors for Bemis, Inc. (BMS) serving on the company’s Audit Committee.

A member of Mylan’s Executive Leadership Team, she ensures markets around the world are optimally prepared to launch and grow pipeline products, including, Respiratory, Infectious Disease, and Biosimilar across Immunology and Oncology.  

Previously, Gulfo served as President and General Manager of Pfizer's U.S. Primary Care business unit, which generated over $12 Billion in revenue.  Earlier in her career at Pfizer, she was responsible for the launch of LIPITOR®, the world's best-selling medicine. She was recognized for her leadership in marketing and medical education campaigns that helped to establish the significance of lowering cholesterol in preventing and managing heart disease.

Gulfo also served as Pfizer’s President of Latin America. In this capacity, she led a team of more than 4,000 colleagues across two dozen countries, and grew revenue to more than $3 Billion while delivering double-digit bottom line growth.

Prior to joining Pfizer, Gulfo led AstraZeneca’s multi-billion-dollar cardiovascular business. Among her achievements, she grew Toprol-XL® sales from $200 million to $2 billion and launched cholesterol-lowering medicine Crestor® with a significantly differentiated life-cycle development program, growing it to a more than $2 billion product in 2009. She then became vice president of Business Development, Innovation and Design for Launch at Astra-Zeneca Pharmaceuticals.

Trained as a scientist with experience in both operational and strategic roles, Gulfo has been awarded five U.S. patents for innovative packaging designed to help patients adhere to their medicines. She serves as an innovation advisor to PARTNERS Healthcare, the $10 billion Boston-based healthcare system, and Cleveland Clinic’s Innovation Center. She also serves on the board of directors for Volunteers of America (VOA) – Greater New York, and is a member of the Committee of 200 (C200), the world’s premier women’s business leadership organization. 

Among many honors, she is especially proud of receiving the 2015 Pinnacle in Leadership Award for STEM from the Girl Scouts of Greater New York, and being honored as one of the top 100 Corporate Leaders in STEM.  In 2014, she was inducted into the Pinnacle Society at Fairleigh Dickinson University and was honored at the Executive Women of New Jersey’s “Salute to the Policy Makers.”  She received the 2012 C200 Luminary Award for Corporate Innovation, and the 2013 Oracle Award by Springboard Enterprises, which is bestowed by an expert network of innovators and investors dedicated to building high-growth technology-oriented companies led by women.

She frequently speaks at leading industry and business conferences including The Wall Street Journal’s “Women in the Economy”, and has been featured in Fortune, Forbes, BusinessWeek, The International Consortium for Executive Development Research (ICEDR) and The Wall Street Journal.

She holds a bachelor's degree in biology from Seton Hall University and an MBA from Fairleigh Dickinson University. She also studied post-graduate Molecular Biology and began her career at the University of Medicine and Dentistry of New Jersey.

Anna Haghgooie, Managing Director, Healthcare, Sandbox Industries and Board Member, Allay, Axial Healthcare, Benestream, Contessa Health, ZeOmega, and Everymove
Panelist - Getting on the radar of growth equity boards: what do they look for in independent candidates?
haghgooie, anna.jpg

Anna Haghgooie is a managing director of Sandbox Industries, a Chicago-based venture capital firm focused on implementing innovation by connecting established corporations with innovative startups and entrepreneurs. Anna focuses on investing in healthcare innovation through the BlueCross BlueShield Venture Funds, a collaborative investment platform with over $550 million in capital and over 30 Blue Plans participating. She currently serves on the board of directors of ExactCare, Somatus, ZeOmega, Contessa, Axial Healthcare, Allay, and higi. Previously she served on the board of directors of naviHealth and Change Healthcare and was a board observer of Essence Group Healthcare. Before joining Sandbox in 2008, Anna held roles as the general manager at an integrative medicine start-up, covered the healthcare markets as an associate director of corporate finance at Fitch Ratings and started her career in the Financial Management Program at GE Capital. Anna earned a bachelor's degree from the University of Michigan and a MBA with honors from the University of Chicago Booth School of Business. Anna is a Fellow in the Health Innovators Fellowship at the Aspen Institute. She lives in Chicago, IL with her husband and two children.

Colin Hill, Chairman, CEO and Co-Founder, GNS Healthcare
Panelist - How do nominating committees and boards evaluate candidates?
Hill, Colin.png

Colin Hill co-founded GNS Healthcare in 2000 and has served as Chairman & CEO since then. He brings impressive leadership experience and a solid track record in commercializing machine learning technology and precision medicine platforms in the biopharmaceutical and managed care industries. In 2016, he was appointed to the board of directors of a leading publicly traded mobile health company that pioneered remote cardiac monitoring – Biotelemetry Inc. (formerly CardioNet) (NASDAQ: BEAT). He was appointed in 2015 by Massachusetts Governor Charlie Baker to the board of directors of the Center for Health Information and Analysis. He is also a founding board member of Transforming Medicine: The Elizabeth Kauffman Institute, a non-profit foundation (501c3) dedicated to the advancement of personalized medicine.

He was a founding member of the Board of Directors of AesRx, a biopharmaceutical company dedicated to the development of new treatments for sickle cell disease (acquired by Baxter in 2014). Colin was the founding chairman of O’Reilly Media’s Strata Rx in 2012, the first healthcare big data conference in the industry. Colin was the founding chairman of big data quantitative trading firm Fina Technologies and served from 2008 to 2011. In 2004, Colin was named to MIT Technology Review’s TR100 list of the top 100 innovators in the world under the age of 35.

He is a frequent speaker at national and international scientific and industry conferences including America’s Health Insurance Plans (AHIP) annual meeting, the Pharmaceutical Researchers & Manufacturers of America (PhRMA) annual meeting, and the Forbes Healthcare Summit, and has been quoted in and appeared in numerous publications and television programs, including The Wall Street Journal, CNBC Morning Call & SquawkBox, Nature, Boston Globe, Politico, Forbes, Wired, and The Economist.

He graduated from Virginia Tech with a degree in physics and earned Master’s degrees in physics from both McGill University and Cornell University.

Jodi Hubler, Managing Director, Lemhi Ventures and Board Member, Bind, Digital Reasoning, PlanSource, PokitDok, and Recondo Technology
Panelist - Getting on the radar of growth equity boards: what do they look for in independent candidates?
Hubler, Jodi.jpg

Jodi Hubler is the Managing Director of Lemhi Ventures, a health care services venture capital fund with $335M under management. For over a decade, Lemhi has invested in companies that transform and disrupt health care. Jodi is known as insightful and direct, whether as a strategic advisor or mentor to entrepreneurs and CEOs or as an investor and board member. She focuses on leadership, culture change, business strategy alignment, governance, and operational excellence in Lemhi and its portfolio companies.

Over her 20-year career, she has held executive positions in a variety of public and private companies, including a lead role in global human resource re-engineering efforts for Cargill; driving systems to support lean manufacturing and process change for a $2B division of Alcoa; and start-up experience with venture-backed Definity Health, where she served as chief people officer. Definity Health was ultimately acquired by United Health Group for more than $300M.

Jodi is a graduate of the University of Iowa Tippie College of Business, with a B.A. in Administration and a M.A. in Industrial Relations. Jodi currently serves on the boards of Bind, Digital Reasoning, PokitDok, and PlanSource and serves as Chair of Recondo Technology. Jodi previously served on the boards of Carol, DNA Direct, Destination Rx, Liazon, OneHealth Solutions (Chair), RetraceHealth (Chair) and ShareableInk. She is a frequent panelist at venture capital conferences and is a member of the Healthcare Executives Leadership Network.

Andrew Lindner, Managing Partner, Frontier Capital, and Board Member, AccessOne, Planet Risk, Tango, and Viverae
Panelist - Getting on the radar of growth equity boards: what do they look for in independent candidates?
Lindner, Andrew.jpg

Andrew Lindner, Managing Partner of Frontier Capital, co-founded the firm in 1999. His primary focus is on the firm’s Vertical SaaS and Healthcare IT investment activities.

Prior to co-founding Frontier, Andrew was with Atlanta-based Stephens, Inc. and also worked in the investment banking division of Bank of America. Andrew currently serves on the boards of The Children’s Scholarship Fund of Charlotte, The Fletcher School, and Charlotte Heptathlon, and formerly served on the board of Teladoc.

Andrew enjoys spending time with his family in Hilton Head Island, playing the guitar, volunteering and spends far too much time following Bruce Springsteen on tour.

Mary Anne Mason, CEO, Mason Strategic Advisors and board consultant and observer
Moderator - Getting on the radar of growth equity boards: what do they look for in independent candidates?
Speaker - Developing your elevator pitch for board service
Mason, Mary Anne.jpg

Mary Anne Mason is the Chief Executive Officer of Mason Strategic Advisors. She has had the privilege of leading merger and acquisition activity, holding general management roles, building business development teams, and leading sales and marketing executives for over 3 decades. Her experience includesboth private equity backed and publicly traded companies.

Mary Anne helps healthcare companies tackle strategic challenges, enhance go-to-market strategy, connect with opportunities in the market and accelerate growth. Relevant to today’s program, she works with a number of private equity and growth equity firms, serving in both consultant and board observer roles.  She has worked with firms as they have built boards, selected new members, and identified and filled experience gaps on their boards of directors and senior management.  Her unparalleled network and unique ability to identify and foster strong relationships on behalf of her clients makes her an invaluable resource to these firms and their boards.

In addition to advising on board-related matters, through a combination of dynamic professional development programs, consulting services, and deep experience in the market, Mary Anne provides unique perspectives and powerful tools to help clients optimize strategy and drive growth. Mary Anne focuses on tech enabled/health services portfolio companies of venture capital and private equity firms.  

Mary Anne’s experience includes leading business development and client engage­ment for health plan/emerging markets at Healthways and Axia Health Management, a well-being improvement company best known for its SilverSneakers Fitness Pro­gram. Axia began as a startup and was later successfully sold to Healthways for $450 million. She also led business development for Caremark, a company that grew from a start-up physician practice management business to a billion dollars in revenue in four years. Prior to Caremark, Mary Anne was general manager for a $300 million division of Baxter International. She is also a former executive of American Hospital Supply and Univita Health.  She currently serves as a board observer for Linkwell Health.

Mary Anne is Chair of the Membership Committee of WBL, a non-profit organization for women leading executive teams crossing the silos of insurance, hospitals, life sciences and specialty healthcare organizations.

Kathy McElligott, Executive Vice President, Chief Information Officer and Chief Technology Officer, McKesson Corporation and Board Member, ArcBest (NASDAQ: ARCB)
Panelist - How do nominating committees and boards evaluate candidates?
McElligott, Kathy.jpg

Kathy McElligott is Executive Vice President, Chief Information Officer and Chief Technology Officer of McKesson Corporation. As CIO, McElligott is responsible for all technology initiatives within the corporation. As CTO, McElligott guides the overall technology direction for the company’s healthcare technology products, and provides support and guidance for application development processes companywide.

Prior to McKesson, McElligott served as the CIO of Emerson, a St. Louis-based global manufacturing and technology company, where she managed the company’s information technology strategy and information security for its global operations, including hardware, software, and services, as well as its telecommunications and data center infrastructure. In her 15 years at Emerson, McElligott held a variety of executive positions including vice president of Information Technology for Emerson Industrial Automation and vice president of Information Technology for Emerson Power Transmission. Previously, McElligott spent 22 years with General Electric, holding multiple information systems leadership roles, ultimately becoming CIO of supply chain for GE Aircraft Engines.

McElligott sits on the board of directors at ArcBest, a publicly traded $2.6B freight transportation and logistics company. While in St. Louis, McElligott was a member of theboard of trustees for Fontbonne University, the industry advisory council of Washington University and member on the St. Louis CIO Board. McElligott is also a member of the CIO Strategy Exchange, a small and selective multi-sponsor program for chief information officers from the most forward-looking companies.

McElligott holds a Bachelor of Business Administration degree in computer science from Kent State University and a master’s degree in business management from Xavier University.

Julie McHugh, Board Member, Aerie Pharmaceuticals (NASDAQ: AERI), Trevena, Inc. (NASDAQ: TRVN), Ironwood Pharmaceuticals (NASDAQ: IRWD), Lantheus Medical Imaging, and The New Xellia Group
Panelist - The interview & diligence process: what to consider
McHugh, Julie.jpg

Julie McHugh has worked in the biopharmaceutical industry for over 30 years, including positions at Endo Health Solutions, Nora Therapeutics, Johnson & Johnson, Centocor, Astra-Merck, Rhone-Poulenc Rorer, and SmithKline Beckman. She has led numerous organizations ranging from start-up companies to large multinational organizations and launched numerous products that have become multi-billion dollar franchises. In addition, she serves on the Boards of public and private companies including Aerie Pharmaceuticals, Ironwood Pharmaceuticals, Lantheus Medical Imaging, Trevena Pharmaceuticals and Xellia Pharmaceuticals. Previously, Julie served on the boards of Viropharma Inc, and Epirus Biopharmaceuticals.  She is currently a strategic advisor to HealthCare Royalty Partners and is the Vice Chairman of the Board of Visitors for the Smeal College of Business at Penn State.

Terry Rappuhn, Board Member, Genesis Healthcare (NYSE: GEN), and Akorn, Inc. (NASDAQ: AKRX)
Panelist - Locating and securing public board opportunities
rappuhn, terry.jpg

Terry Allison Rappuhn is an experienced board member. She has served on the boards of 5 public companies with market capitalizations ranging from $80 million to $5 billion. She served as an audit committee member and financial expert for all 5 boards, and audit committee chairperson on 3 of them. Previously, she was the CFO of Quorum Health Group, an owner and operator of acute care hospitals. Ms. Rappuhn has 15 years of experience with Ernst & Young, LLP and is a Certified Public Accountant.

Terry focuses on helping rapidly growing companies build infrastructure, processes, and teams. She coaches leadership teams through significant and successful transformations. She currently is a director of Akorn, Inc. (NASDAQ: AKRX), a specialty pharmaceutical company.

From 2003 to 2007, she was a member of the board of Genesis HealthCare Corporation. Genesis was acquired and take private, at which time the existing board was dissolved. After a 10-year absence, she was elected to the board of Genesis Healthcare, Inc. (NYSE: GEN), where she serves today. Genesis is one of the nation's largest post-acute care providers with more than 450 facilities in 30 states nationwide.

Terry previously served as a director of Span-America Medical Systems, Inc. and AGA Medical Holdings, Inc.

Terry is passionate about the consumer's healthcare experience. She has served as project leader for Healthcare Financial Management Association (HFMA)'s Patient Friendly Billing initiative, which promotes patient-focused practices and engagement. She also has advised HFMA's Value Project, which provides tools and insights to enable health systems to transition from volume pricing to value pricing. Terry maintains an active network of healthcare industry leaders.

Peggy Scott, Board Chair and Interim CEO, Cleco Corporate Holdings, and former COO, CFO, and Chief Strategy Officer, Blue Cross/Blue Shield of Louisiana
Speaker - What is your value proposition to boards as a healthcare executive?
Scott, Peggy.jpg

A former healthcare executive, Peggy adds value to diverse industries. Currently, she is Board Chair and interim CEO of CLECO, a $6B power company. She serves on governance, PR and business planning committees. As Audit Chair, she oversaw SEC filings.

Previously, Executive VP/COO/CFO of Blue Cross/Blue Shield of LA, Peggy served as Chief Strategy Officer leading transformation under the ACA. In her distinguished earlier accounting career, she quickly became Deloitte’s first female office Managing Partner in their 100-year history.

Peggy draws on unique experience in both insurers and fully integrated healthcare organizations spanning hospitals to hospice. Skilled in reinventing large complex U.S./International companies undergoing change, she served as EVP/COO/CFO at Novant, Pan-American and General Health. She led transformations, grew companies organically and with M&A, and headed operations and finance in eight countries.

Peggy advises healthcare, technology and PE companies. She is a consultant for Francisco Partners and serves on Health Catalyst Capital and ClearDATA’s advisory boards. A past President, Peggy serves on LSU’s College of Business Dean’s Council and on the Blue Cross Foundation board, having served as Chair/CEO.

Prior Boards: International Plan Solutions, LLC; Partners National Health Plans; LA Superdome; Latin American Corporations. Former Adjunct Professor Tulane Medical School.

Honors: Wall Street Journal and Strategic Finance features as National Financial Executive of the Year; American Institute of CPAs Hall of Fame; Business Insurance Woman to Watch; LSU Alumni Hall of Distinction; Reagan presidential citation.

Certifications: CPA; Certified in Valuations/Forensics; ACCD and NACD director certified; Tulane MBA; LSU B.S. Accounting

Lynn Shapiro Snyder, Founder and President, WBL, and Senior Member, EpsteinBeckerGreen PC and Board Member, Trustmark Companies, EpsteinBeckerGreen, Savor Health, Team Better, and the Maryland/Israel Development Center
Speaker - The ROI of board membership: is it worth it? & Large private equity firms and the independent director
Snyder, Lynn.jpg

Lynn Shapiro Snyder is a Board Member and Senior Member of EpsteinBeckerGreen in Washington, D.C., a law firm with one of the largest health care and life sciences practices in the country.  There, she advises all types of health care companies and companies such as private equity firms that work with health care.  She is well- known for her expertise in FDA, Medicare, Medicaid and managed care issues whether it is in connection with the launch of a new product or defending a company under a fraud investigation. She has been at EpsteinBeckerGreen for over 35 years.

Additionally, Lynn is the founder of WBL, a non-profit that connects and convenes senior executive women from all across the health care industry.  WBL’s focus is on helping these women expand their leadership, such as by serving on a board of directors, and the organization has helped to propel hundreds of women to board directorships.  Named a “Director to Watch,” Lynn is a leader in the governance arena and is the co-author of Answering the Call: Understanding the Duties, Risks & Rewards of Corporate Governance – a book to educate busy executives about board service. She also is the author of Advancing Women in Business – 10 Best Practices.

Her current board memberships include Trustmark Companies, EpsteinBeckerGreen, Savor Health, Team Better, and the Maryland/Israel Development Center.

Harvey Sigelbaum, Senior Advisor, Riverside Company, and Board Member, Medical Payment Exchange, Inc., International Fidelity Insurance Company, Allegheny Casualty Company, SourceOne Global Partners, LLC Advisory Board, and My Nexus, Inc. Advisory Board; Former Chariman, President, & CEO, MultiPlan, Inc.
Panelist - Exceeding expectations as an effective new director
Sigelbaum, Harvey.jpg

Harvey C. Sigelbaum is a Senior Advisor for the Riverside Company, a global private equity firm. Prior to joining Riverside, Mr. Sigelbaum served as President and Co-CEO, then Executive Chairman, of MultiPlan, Inc., one of the country’s largest healthcare network organizations. Previously, Mr. Sigelbaum worked for 17 years as President and CEO of Amalgamated Life Insurance Company, a New York domiciled, “A” rated, national insurer specializing in multi-state employee benefit plans. Prior to that he was President and CEO of Urban Community Insurance Company, a New York domiciled, “A” rated, regional auto insurer.

Mr. Sigelbaum has been active on a number of Boards, both for-profit and non-profit, including service as Chairman of NCB, a Washington, D.C. headquartered national bank, with offices throughout the USA; Chairman, National Cooperative Business Association/Cooperative League of the USA (NCBA/CLUSA); Chairman, New York State Insurance Department Advisory Council; and Chairman, National Association on Drug Abuse Problems. Other Board activity included Executive Committee, America’s Health Insurance Plans; Executive Committee, Council for Affordable Quality Healthcare; Health Insurance Association of America; American Association of Health Plans; Association of Managed Healthcare Organizations; Life Insurance Council of New York; Industrial Council for Managed Care; New York Urban Coalition; Americas Association of Cooperative/Mutual Insurance Societies (International Cooperative & Mutual Insurance Federation); NCB Development Corporation; United Housing Foundation; Overseas Cooperative Development Council; Care Management International, Inc.; FairPay Solutions, Inc.; Universal SmartComp, LLC; Medical Payment Exchange, Inc.; Allegheny Casualty Company; and International Fidelity Insurance Company. He also has served/serves on various Advisory Boards including MedeAnalytics, Inc.; SourceOne Global Partners, LLC; and MyNexus, Inc.

He served/serves as well on the Ambassadors Council of Freedom from Hunger, the Board of the Shelley and Donald Rubin Foundation and the Board of the Forward Association, a non-profit publisher of digital and print media.

In addition, Mr. Sigelbaum served on the Board of Directors of the Overseas Private Investment Corporation (OPIC), a self-sustaining U.S. Government agency that provides political risk insurance and financing for U.S. businesses investing in emerging markets and developing nations around the world. Appointed by President Clinton in 1994, Mr. Sigelbaum was confirmed to this position by the U.S. Senate.

Mr. Sigelbaum is an attorney, admitted to the New York Bar in 1963, currently retired from the practice of law. He has served as Adjunct Associate Professor on the faculty of The College of Insurance in New York City, now part of St. John’s University. He is a graduate of the University of Miami and Brooklyn Law School.

Mr. Sigelbaum and his wife, Barbara, live in Manhattan. They have four children and (by last count) nine grandchildren.

Neil Simpkins, Senior Managing Director, Private Equity - New York, Blackstone and Board Member, Gates Corporation, Apria Healthcare Group, Summit Materials, Change Healthcare, and TeamHealth
Speaker - Large private equity firms and the independent director
Simpkins, Neil.jpg

Neil P. Simpkins is a Senior Managing Director of Blackstone in the Private Equity Group. He has global responsibility for portfolio management activities and investments in the healthcare services, packaging, and industrial sectors. Since joining Blackstone in 1998, Mr. Simpkins has led the acquisitions of TRW Automotive, Vanguard Health Systems, TeamHealth, Apria Healthcare Group, Summit Materials, Gates Corporation, and Change Healthcare.

Before joining Blackstone, Mr. Simpkins was a Principal at Bain Capital. While at Bain Capital, Mr. Simpkins was involved in the execution of investments in the consumer products, industrial, healthcare, and information industries. Prior to joining Bain Capital, Mr. Simpkins was a consultant at Bain & Company in the Asia Pacific region and in London. Mr. Simpkins is also Chairman of Americans for Oxford, Inc., Oxford University’s primary charitable organization in North America.

Mr. Simpkins graduated with honors from Oxford University and received an MBA from Harvard Business School. He currently serves as a Director of Gates Corporation, Apria Healthcare Group, Summit Materials, Change Healthcare, and TeamHealth.

Cathy Sohn, Board Member, Jazz Pharmaceuticals (NASDAQ: JAZZ), Landec (NASDAQ: LNDC), and Dohmen Life Science Services, a division of the Dohmen Company
Panelist - The interview & diligence process: what to consider

Catherine Angell Sohn, Pharm.D. is a pharmacist, biopharmaceutical executive,
adjunct professor, and a Certified Licensing Professional (CLP). She is currently Acting Head, Corporate Development at BioAxone Biosciences, a private, clinical stage neuroscience company in Cambridge, the non-executive Chairman of BioEclipse Therapeutics, a private, immuno-oncology company, and an independent Director on the Board of Directors of Jazz Pharmaceuticals (NASDAQ: JAZZ), Landec Corp (NASDAQ: LNDC) and Dohmen Life Science Services (private). She holds the position of Adjunct Professor at the University of California, San Francisco and serves on the board of directors of the not-for-profit World Affairs Council of Philadelphia and is a member of the Investment Committee of Pennsylvania’s Ben Franklin Technology Partners.

Sohn has 30 years of industry experience in business strategy, business development, strategic product development and launch execution. At GlaxoSmithKline plc, she was a member of the global executive team and senior vice president of worldwide business development and strategic alliances in the company’s $6 billion consumer health division where she led a series of US, Europe, and global licensing and M&A deals which delivered over $2 billion in sales. Previously as vice president of Worldwide Strategic Product Development for the Cardiovascular, Metabolic & Pulmonary Therapeutic Areas at SmithKline Beecham (SB) Pharmaceuticals, Sohn was responsible for product strategy,
valuation and strategic commercial leadership of assets from Phase 1 through global life cycle management. As an entrepreneur within a large corporation, Sohn established the US Vaccine Business Unit and led the launch of SB's first vaccine in the US and subsequently, as a member of the global CNS Strategy Team, Sohn helped shape the CNS Life Cycle Pipeline strategy, and then led the U.S. launch of the company's $1 billion CNS product. Sohn served on the Board of Trustees of the Licensing Executive Society (LES), USA and Canada, from 2008-2011, and on the LES Life Science Sector Executive Committee for many years.

Sohn earned a Doctor of Pharmacy (Pharm.D.) degree from the University of California San Francisco in 1977 and a Certificate of Professional Development from The Wharton School at the University of Pennsylvania.

Grover Thomas, Chairman of the Board, StemLab (Portugal), Board Member, US Health Group, Vice Chairman, Grameen Foundation, and former CEO and Chairman of the Board, Trustmark Companies
Panelist - Exceeding expectations as an effective new director
Thomas, Grover.jpg

Mr. Thomas is Chairman of the Board of Stemlab-Crioestáminal, a biotechnology company based in Cantanhede, Portugal, engaged in the preservation of stem cells to treat future critical diseases in children and participation in clinical trials across Europe.  Since 2005, Mr. Thomas been serving on the Board of Directors at USHEALTH Group Inc., a Ft. Worth based insurance company.

Additionally, he is Vice Chairman of the Board of Grameen Foundation, a global nonprofit organization that brings innovative and sustainable solutions to the fight against poverty and hunger.  He previously was a Trustee of Freedom from Hunger from 2005 to 2016 and was Chair of the Freedom from Hunger Board from 2007 to 2011 which merged with Grameen Foundation in 2016. He serves the organization as a spokesperson and networker, contributing his business and governance expertise as well as strategic advice. 

From 2000-2015, he also served as President, CEO and Chairman of the Board of The Trustmark Companies, a nationwide insurance company based in Lake Forest, IL. He has more than 40 years of experience in the financial services industry, particularly the insurance industry, in which he has held a variety of executive and leadership positions.

Mr. Thomas served as a Trustee of the Georgia State University Foundation for 9 years and six years as a Trustee of the Actuarial Foundation. Mr. Thomas holds a Bachelor Degree from Briar Cliff University in Sioux City, Iowa, and an MBA from Georgia State University. He lives in Atlanta, Georgia with his wife, Cathy. They have three children and four grandchildren.